MATERNUS-Kliniken AG (DE:MAK)

XETRA:MAK

MAK

MATERNUS-Kliniken AG

RESEARCH TOOLSreports

Want to see DE:MAK full AI Analyst Report?

MATERNUS-Kliniken AG (MAK) Price & Analysis

2 Followers

MAK Stock Chart & Stats

€0.98

-€0.01(-0.71%)

At close: Jan 08 4:00 PM EST

€0.98

-€0.01(-0.71%)

Day’s Range― - ―

52-Week Range€0.89 - €10.90

Previous CloseN/A

Volume132.00

Average Volume (3M)618.00

Market Cap

€20.76M

Enterprise Value€19.00M

Total Cash (Recent Filing)€2.18M

Total Debt (Recent Filing)€0.00

Price to Earnings (P/E)―

Beta0.57

Next Earnings

Aug 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.72

Shares Outstanding20,970,000

10 Day Avg. Volume1,293

30 Day Avg. Volume618

Financial Highlights & Ratios

PEG Ratio0.29

Price to Book (P/B)-0.43

Price to Sales (P/S)0.25

P/FCF Ratio2.06

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthConsistent revenue growth indicates a stable demand for healthcare services, suggesting resilience in the company's core business model.

Cash Flow ImprovementImproved cash flow generation enhances financial flexibility, allowing the company to invest in growth opportunities and manage debt more effectively.

Gross Profit MarginA strong gross profit margin reflects effective cost control, which can support profitability as the company scales its operations.

Bears Say

High Financial LeverageHigh financial leverage increases financial risk and limits the company's ability to invest in growth or weather economic downturns.

Negative Profitability MarginsPersistent negative profitability margins indicate challenges in managing costs and achieving sustainable profitability, impacting long-term viability.

Negative EquityNegative equity highlights potential solvency issues, which could affect the company's ability to secure financing and invest in future growth.

MAK FAQ

What was MATERNUS-Kliniken AG’s price range in the past 12 months?

MATERNUS-Kliniken AG lowest stock price was €0.89 and its highest was €10.90 in the past 12 months.

What is MATERNUS-Kliniken AG’s market cap?

MATERNUS-Kliniken AG’s market cap is €20.76M.

When is MATERNUS-Kliniken AG’s upcoming earnings report date?

MATERNUS-Kliniken AG’s upcoming earnings report date is Aug 20, 2026 which is in 93 days.

How were MATERNUS-Kliniken AG’s earnings last quarter?

MATERNUS-Kliniken AG released its earnings results on Apr 30, 2026. The company reported -€0.563 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.563.

Is MATERNUS-Kliniken AG overvalued?

According to Wall Street analysts MATERNUS-Kliniken AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MATERNUS-Kliniken AG pay dividends?

MATERNUS-Kliniken AG does not currently pay dividends.

What is MATERNUS-Kliniken AG’s EPS estimate?

MATERNUS-Kliniken AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MATERNUS-Kliniken AG have?

MATERNUS-Kliniken AG has 20,970,000 shares outstanding.

What happened to MATERNUS-Kliniken AG’s price movement after its last earnings report?

MATERNUS-Kliniken AG reported an EPS of -€0.563 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8%.

Which hedge fund is a major shareholder of MATERNUS-Kliniken AG?

Currently, no hedge funds are holding shares in DE:MAK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MATERNUS-Kliniken AG Stock Smart Score

Neutral

Technicals

Top Smart Score Stocks >

Company Description

MATERNUS-Kliniken AG

Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company was founded in 1877 and is headquartered in Berlin, Germany.